Abstract
Background: Drug loaded microparticles are widely used to improve the therapeutic value of various water soluble/insoluble drugs and provides sustained drug release for longer duration of time.
Objective: To develop Diclofenac sodium (DS) loaded - ethylcellulose microparticles.
Method: Diclofenac sodium (DS) loaded ethylcellulose microparticles were prepared by oil-in-water solvent evaporation method using design of experiments. The effect of three formulation variables (independent variables) like amount of DS, ethylcellulose (EC) and polyvinyl alcohol (PVA) was investigated using 23 experimental design to enhance the encapsulation efficiency (E.E.) (dependent variable) of microparticles.
Results: The microparticles were evaluated for surface morphology, E.E., and in vitro drug release. The physicochemical characteristics of the microparticles were assessed using Fourier transform infrared spectroscopy (FTIR), X-ray powder diffractometry (XRPD), and Field emission scanning electron microscopy. The E.E. of the microparticles was ranged from 37.21 ± 0.87% to 72.20 ± 1.32%. An optimum combination of formulation variables are predicted as 1000 mg DS, 1000 mg EC and 0.1% w/v of PVA, which corresponds to E.E. of 73.71 ± 3.5 % and suitably sustained the DS delivery.
Conclusion: The microparticles were found discrete and spherical. The absence of drug polymer interaction was confirmed by FTIR spectroscopy. The XRPD revealed the distribution of drug within the microparticles formulation. In vitro drug release from microparticles showed a sustained drug release pattern over a period of 16 h with initial burst effect.
Keywords: Diclofenac sodium, ethylcellulose, microencapsulation, microparticles, drug delivery, 23 factorial design approach.
Graphical Abstract
Micro and Nanosystems
Title:Formulation of Diclofenac Sodium-Loaded Ethylcellulose Microparticles Using 23 Factorial Design Approach
Volume: 9 Issue: 1
Author(s): Rameshwar K. Deshmukh and Jitendra B. Naik*
Affiliation:
- Department of Pharmaceutical Technology, University Institute of Chemical Technology, North Maharashtra University, Umavi Nagar, Post Box No. 80, Jalgaon-425 001, Maharashtra,India
Keywords: Diclofenac sodium, ethylcellulose, microencapsulation, microparticles, drug delivery, 23 factorial design approach.
Abstract: Background: Drug loaded microparticles are widely used to improve the therapeutic value of various water soluble/insoluble drugs and provides sustained drug release for longer duration of time.
Objective: To develop Diclofenac sodium (DS) loaded - ethylcellulose microparticles.
Method: Diclofenac sodium (DS) loaded ethylcellulose microparticles were prepared by oil-in-water solvent evaporation method using design of experiments. The effect of three formulation variables (independent variables) like amount of DS, ethylcellulose (EC) and polyvinyl alcohol (PVA) was investigated using 23 experimental design to enhance the encapsulation efficiency (E.E.) (dependent variable) of microparticles.
Results: The microparticles were evaluated for surface morphology, E.E., and in vitro drug release. The physicochemical characteristics of the microparticles were assessed using Fourier transform infrared spectroscopy (FTIR), X-ray powder diffractometry (XRPD), and Field emission scanning electron microscopy. The E.E. of the microparticles was ranged from 37.21 ± 0.87% to 72.20 ± 1.32%. An optimum combination of formulation variables are predicted as 1000 mg DS, 1000 mg EC and 0.1% w/v of PVA, which corresponds to E.E. of 73.71 ± 3.5 % and suitably sustained the DS delivery.
Conclusion: The microparticles were found discrete and spherical. The absence of drug polymer interaction was confirmed by FTIR spectroscopy. The XRPD revealed the distribution of drug within the microparticles formulation. In vitro drug release from microparticles showed a sustained drug release pattern over a period of 16 h with initial burst effect.
Export Options
About this article
Cite this article as:
Deshmukh K. Rameshwar and Naik B. Jitendra *, Formulation of Diclofenac Sodium-Loaded Ethylcellulose Microparticles Using 23 Factorial Design Approach, Micro and Nanosystems 2017; 9 (1) . https://dx.doi.org/10.2174/1876402909666170531074453
DOI https://dx.doi.org/10.2174/1876402909666170531074453 |
Print ISSN 1876-4029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1876-4037 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Oral Inflammation and Bacteremia: Implications for Chronic and Acute Systemic Diseases Involving Major Organs
Cardiovascular & Hematological Disorders-Drug Targets Identification of AHSA1 as a Potential Therapeutic Target for Breast Cancer: Bioinformatics Analysis and <i>in vitro</i> Studies
Current Cancer Drug Targets Molecular Aspects of Intestinal Radiation-Induced Fibrosis
Current Molecular Medicine Antiangiogenic Therapy and Ovarian Cancer
Current Women`s Health Reviews Endothelial Dysfunction: Methods of Assessment & Implications for Cardiovascular Diseases
Current Pharmaceutical Design Biologic Therapy in Rheumatoid Arthritis
Current Topics in Medicinal Chemistry HSP60 as a Drug Target
Current Pharmaceutical Design Patent Selections:
Recent Patents on Inflammation & Allergy Drug Discovery The Association of Collagenase with Human Diseases and its Therapeutic Potential in Overcoming them
Current Biotechnology The mTOR/4E-BP1/eIF4E Signalling Pathway as a Source of Cancer Drug Targets
Current Medicinal Chemistry Targeting Angiogenesis in Ovarian Carcinoma
Current Cancer Therapy Reviews Is Metformin a Therapeutic Paradigm for Colorectal Cancer: Insight into the Molecular Pathway?
Current Drug Targets P-Selectin Antagonism in Inflammatory Disease
Current Pharmaceutical Design Patent Selections
Recent Patents on Inflammation & Allergy Drug Discovery Delivery of siRNA to the Target Cell Cytoplasm: Photochemical Internalization Facilitates Endosomal Escape and Improves Silencing Efficiency, In Vitro and In Vivo
Current Pharmaceutical Design The Role of Diet Related Short-Chain Fatty Acids in Colorectal Cancer Metabolism and Survival: Prevention and Therapeutic Implications
Current Medicinal Chemistry Dietary Fiber Gap and Host Gut Microbiota
Protein & Peptide Letters Trefoil Factor Family (TFF) Peptides and their Different Roles in the Mucosal Innate Immune Defense and More: An Update
Current Medicinal Chemistry Disorders of Innate Immunity in Human ageing and effects of Nutraceutical Administration
Endocrine, Metabolic & Immune Disorders - Drug Targets Tyrosine Kinases and Inflammatory Signalling
Current Molecular Medicine